Argentina on Wednesday launched the first working group of a new national agency to regularize and promote the country’s nascent cannabis industry, which ministers hope will create new jobs and exports generating fresh income for the South American nation. “This opens the door for Argentina to start a new path in terms of industrial exports, on the basis of huge global demand,” said Economy Minister Sergio Massa in a conference launching the national hemp and…
A new survey shows how frequently cannabis is used to treat chronic pain. Fifty million American adults (20 percent) suffer from chronic pain, with almost 20 million having high-impact chronic pain, defined as substantially restricting activities for six months or more. A new study, reviewed by Johns Hopkins School of Public Health, now shows how well-accepted cannabis has become as a treatment for chronic pain in states permitting its medicinal use. Research on medical cannabis…
Cannabis use could be the key to multiple orgasms among women – as less than 50 percent report climaxing during a sexual encounter. A new survey of hundreds of people showed that women who smoke before sex or masturbate have improved orgasm capacity per encounter. The study, conducted by North Carolina researchers, suggested this is likely due to the drug making women relaxed and increasing their desire, which means the recreational drug could treat sexual…
Since the passage of the 2018 Farm Bill, the hemp CBD industry has been eagerly awaiting FDA CBD regulations. In that time, FDA convened a working group to study how the agency would regulate CBD foods and dietary supplements. As of January 26, 2023, the FDA concluded that it will NOT regulate CBD foods or dietary supplements.
FDA and the States on CBD since the Farm Bill
Before jumping into the post, it bears noting that the FDA has taken the position, literally since the day the 2018 Farm Bill was passed, that CBD foods and dietary supplements violate the Food, Drug & Cosmetic Act. Nevertheless, it has issued only periodic warning letters and taken minimal actions against the CBD industry beyond these letters. The agency has also tended to focus more on egregious misconduct.
In the face of the FDA’s limited responses, states have filled the void with their own regulations, though we always knew the FDA was considering CBD food and dietary supplement regulations.
Now, the FDA is declining to move forward with regulations but has indicated that it would work with Congress if it passes separate CBD legislation. This is because the FDA concluded that its existing
On Wednesday, February 1, 2023 at 2pm EST, Simon Malinowski will host a free, hour-long webinar to answer any questions about New York’s adult-use cannabis rules and regulations.
Simon is our lead New York cannabis attorney, based in Manhattan. He will cover a variety of topics including the application process, anticipated timelines and license types.
Please feel free to submit your questions in advance. Questions will also be taken throughout the presentation!